BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Issue 1 (20th November 2020)
- Record Type:
- Journal Article
- Title:
- BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Issue 1 (20th November 2020)
- Main Title:
- BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN
- Authors:
- Deng, Rong
Guo, Yanmin
Li, Lian
He, Jianfeng
Qiang, Zhe
Zhang, Hailong
Chen, Ran
Wang, Yanli
Zhao, Xian
Yu, Jianxiu - Abstract:
- Abstract : Deubiquitinase BAP1 is an important tumor suppressor in several malignancies, but its functions and critical substrates in prostate cancer (PCa) remain unclear. Here, we report that the mRNA and protein expression levels of BAP1 are downregulated in clinical PCa specimens. BAP1 can physically bind to and deubiquitinate PTEN, which inhibits the ubiquitination‐mediated degradation of PTEN and thus stabilizes PTEN protein. Ectopically expressed BAP1 in PCa cells increases PTEN protein level and subsequently inhibits the AKT signaling pathway, thus suppressing PCa progression. Conversely, knockdown of BAP1 in PCa cells leads to the decrease in PTEN protein level and the activation of the Akt signaling pathway, therefore promoting malignant transformation and cancer metastasis. However, these can be reversed by the re‐expression of PTEN. More importantly, we found that BAP1 protein level positively correlates with PTEN in a substantial fraction of human cancers. These findings demonstrate that BAP1 is an important deubiquitinase of PTEN for its stability and the BAP1‐PTEN signaling axis plays a crucial role in tumor suppression. Abstract : PTEN protein levels are regulated through ubiquitination. Here, we identify BAP1 as a deubiquitinase that physically binds to and deubiquitinates PTEN, thereby inhibiting PTEN degradation. Stabilized PTEN suppresses prostate cancer progression by inhibiting Akt phosphorylation.
- Is Part Of:
- Molecular oncology. Volume 15:Issue 1(2021)
- Journal:
- Molecular oncology
- Issue:
- Volume 15:Issue 1(2021)
- Issue Display:
- Volume 15, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2021-0015-0001-0000
- Page Start:
- 279
- Page End:
- 298
- Publication Date:
- 2020-11-20
- Subjects:
- BAP1 -- cancer progression -- deubiquitination -- prostate cancer -- PTEN
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.12844 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23865.xml